Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis  John Gubatan, Shuji Mitsuhashi, Talia Zenlea, Laura Rosenberg, Simon Robson, Alan C. Moss  Clinical Gastroenterology and Hepatology  Volume 15, Issue 2, Pages 240-246.e1 (February 2017) DOI: 10.1016/j.cgh.2016.05.035 Copyright © 2017 AGA Institute Terms and Conditions

Figure 1 Distribution of serum vitamin D levels among ulcerative colitis patients by clinical relapse status at 12 months. Clinical Gastroenterology and Hepatology 2017 15, 240-246.e1DOI: (10.1016/j.cgh.2016.05.035) Copyright © 2017 AGA Institute Terms and Conditions

Figure 2 Receiver Operating Characteristic (ROC) curve of serum vitamin D levels for the outcome of clinical relapse. Clinical Gastroenterology and Hepatology 2017 15, 240-246.e1DOI: (10.1016/j.cgh.2016.05.035) Copyright © 2017 AGA Institute Terms and Conditions

Figure 3 Time to event analysis of the effect of serum vitamin D levels on risk of clinical relapse in ulcerative colitis patients in remission. Clinical Gastroenterology and Hepatology 2017 15, 240-246.e1DOI: (10.1016/j.cgh.2016.05.035) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 1 Baseline SCCAI among prospective cohort (N = 70). All patients were in clinical remission with SCCAI of 2 or less at time of enrollment. Clinical Gastroenterology and Hepatology 2017 15, 240-246.e1DOI: (10.1016/j.cgh.2016.05.035) Copyright © 2017 AGA Institute Terms and Conditions